Ileal Crohn's Disease. A case report

Authors

  • Beatriz Di Martino Ortiz Profesor Asistente. Cátedra de Dermatología. Hospital de Clínicas. Facultad de Ciencias Médicas. San Lorenzo - Paraguay.
  • J Ortiz Villalba Profesor Adjunto. Departamento de Gastroenterología y Endoscopia Digestiva. Hospital de Clínicas. Facultad de Ciencias Médicas.
  • H Macchi Salim Profesor Adjunto. Departamento de Gastroenterología y Endoscopia Digestiva. Hospital de Clínicas. Facultad de Ciencias Médicas

DOI:

https://doi.org/10.18004/anales/2017.050(01)61-068

Keywords:

inflammatory bowel disease, Crohn's disease, ileitis, Paraguay

Abstract

The term Inflammatory Bowel Disease (IBD) includes a group of clinical entities that are characterized by chronic inflammatory processes of unknown etiology, and primarily, but not exclusively, affecting the intestine. Currently, several entities are included in this concept: Ulcerative Colitis (UC), Crohn's Disease (CD), Unclassified Colitis (UC), Microscopic Colitis (CM) and Reservoritis (Pouchitis). Crohn's Disease can affect any part of the intestine, with the most frequent location being ileal and colonic simultaneously. The inflammatory process in CD is transmural and its fundamental symptoms are usually chronic diarrhea and/or abdominal pain. We present the case of a young woman with a CD that exclusively compromises the terminal Ileon, in whom the diagnosis of ileal CD was performed with the clinical data, the endoscopic procedure and the pathological study, who responded satisfactorily to the established therapy, and the concept of CD with an emphasis on its diagnosis is reviewed.

References

1. Gassull MA, Gomollón F, Obrador A, Hinojosa J, eds. Enfermedad Inflamatoria Intestinal, 2.ª edición. Ergon. Madrid, 2002.

2. Van Assche G, Dignass A, Panés J, Beaugerie L, Karagiannis J, Allez M et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease. J Crohns Colitis 2010; 4: 7-27.

3. Dignass A, Van Assche G, Lindsay JO, Lémman M, Söderholm J, Colombel JF et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease. Current management. J Crohns Colitis 2010; 4: 28-62.

4. Franke A, McGovern DPB, Barrett JC, Wang K, Randford-Smith GL, Ahmad T et al. Genomewide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genetics 2010; 42: 1118-1126.

5. Silverberg M, Satsangi J, Ahmad T, Arnott I, Bernstein Ch, Brandt SR et al. Toward and integrated clinical, molecular, and serological classification of inflammatory bowel disease: report or a working party of the Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19(Suppl A): 5A-36A.

6. Nos P, Clofent J. Enfermedad de Crohn. En Ponce J (editor) Tratamiento de las Enfermedades Gastroenterológicas. AEG. Elsevier. Barcelona, 2010:293-304.

7. Hinojosa J, Roig JJ. Afectación perianal en la enfermedad de Crohn. En: Ponce J,ed. Tratamiento de las Enfermedades Gastroenterológicas. AEG. Elsevier. Barcelona, 2010:306-318.

Downloads

Published

2026-10-20

How to Cite

Ileal Crohn’s Disease. A case report. (2026). Anales of the Faculty of Medical Sciences, 50(1), 61-68. https://doi.org/10.18004/anales/2017.050(01)61-068